Patrizia Murer

Patrizia Murer

Company: Anaevon

Job title: Head of Protein Engineering


Development of ANV419, a Novel CD122-Selective IL-2 Fusion Antibody With Potent CD8 T Cell & NK Cell Stimulatory Function 11:30 am

Delve into ANV419, a rationally designed non-alpha IL-2/anti-IL-2 antibody fusion protein and is engineered to lack CD25 binding activity but retains CD122 affinity comparable to native IL-2. Learn how in vitro and animal studies demonstrate that ANV419 selectively proliferates CD8 T cells and NK cells over regulatory T cells resulting in potent anti-tumor activity. Understand…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.